Quantcast

Latest Phenols Stories

2014-06-10 08:29:27

RALEIGH, N.C., June 10, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will present at two important upcoming healthcare conferences: 34(th) Annual William Blair Growth Stock ConferenceWednesday, June 11, 20143:20 PM Central Time (4:20 PM Eastern Time)Four Seasons Hotel, Chicago, IL Wells Fargo 2014 Healthcare ConferenceTuesday, June 17, 20144:40 PM Eastern...

2014-06-05 13:33:09

University of Michigan Health System With naloxegol, adults found relief from opioid-induced constipation Pain medicines often lead to constipation for patients seeking long-term pain relief, but an investigational once-daily drug may help, according to study led by the University of Michigan Health System. Globally, approximately 28 million to 35 million, or nearly half, of patients taking opioids for long-term pain develop constipation. Laxatives provide sub-optimal relief. The...

2014-06-05 12:29:48

CHICAGO, June 5, 2014 /PRNewswire/ -- The Centers for Medicare & Medicaid Services (CMS) issued on March 14, 2014 revised guidance, "Requirements for Hospital Medication Administration, Particularly Intravenous (IV) Medications and Post-Operative Care of Patients Receiving IV Opioids". http://photos.prnewswire.com/prnvar/20131024/CG03341LOGO In an open letter to CMS discussing the guidance, the Physician-Patient Alliance for Health & Safety applauds CMS for this guidance as...

2014-06-04 12:30:20

PORTLAND, Ore., June 4, 2014 /PRNewswire/ -- Paragon BioTeck, Inc., a privately held U.S. biopharmaceutical company specializing in the development of ophthalmic pharmaceuticals and therapies, announces its FDA approved Phenylephrine Hydrochloride Ophthalmic Solution, USP 2.5 percent and 10 percent, to dilate the pupil, is readily available through Bausch + Lomb or your primary wholesaler. "Paragon is committed to working proactively with the FDA in an effort to prevent disrupting...

2014-06-03 08:32:29

Multi-Tranche Financing Provides Sufficient Funding to Take KP201 Through and Beyond Potential FDA Approval and Enables KemPharm to Advance its Full Pipeline of Abuse-Deterrent Prodrugs CORALVILLE, Iowa, June 3, 2014 /PRNewswire/ -- KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, announced today that it has entered into a $60 million financing agreement with an investment fund managed by...

2014-05-28 08:32:01

Controlled Substance Analgesic Combination Product Uses Depomed's Proprietary Acuform® Technology NEWARK, Calif., May 28, 2014 /PRNewswire/ -- Depomed, Inc. (NASDAQ:DEPO) announced today that the U. S. Food and Drug Administration (FDA) has accepted for filing a New Drug Application (NDA) from Mallinckrodt (NYSE: MNK) for MNK-155. MNK-155 is an investigational extended-release oral formulation of hydrocodone and acetaminophen that has been studied for the management of moderate to...

2014-05-21 23:10:53

Healthesystems clinicians assembled a valuable resource for workers’ compensation payers to share with prescribers who are treating patients for chronic pain with opioid therapy. Tampa, Fla. (PRWEB) May 21, 2014 Implementation of an aggressive opioid management strategy that includes opioid dose tapering can minimize risks to injured workers and workers’ compensation claims organizations. Long-term opioid therapy carries significant risks and can lead to complex, escalating and...

2014-05-21 08:28:20

- Rapid and effective relief for all racehorses in study MELBOURNE, Australia, May 21, 2014 /PRNewswire/ -- A Phosphagenics Limited (ASX:POH, OTCQX: PPGNY) study using its TPM(®)/Oxycodone topical patch to manage shin soreness pain for thoroughbred racehorses found recovery from pain in all horses within 1-2 days. The study was conducted on six thoroughbreds, between two and three years of age, exhibiting cannon (shin) bone soreness arising from injuries in either one or two...

2014-05-20 16:25:36

Faulty Study Does Not Provide Definitive Answer on Health Benefits of Resveratrol Supplement Intake in Mass Population BOCA RATON, Fla., May 20, 2014 /PRNewswire/ -- Reserveage Nutrition(TM) (www.reserveage.com), a supplement company that has launched more than 140 science-based products and won more than 25 industry awards for excellence, today has released a response to the JAMA Internal Medicine's published study on Resveratrol. With careful consideration, Naomi Whittel, CEO of...

2014-05-14 23:06:44

WCRI's 25-state study, Interstate Variations in Use of Narcotics 2nd Edition, will give public officials, employers, worker advocates, and other stakeholders the ability to examine interstate variations and trends in the use of narcotics and prescribing patterns of pain medications in the workers’ compensation system. Cambridge, MA (PRWEB) May 14, 2014 A new study by the Workers Compensation Research Institute (WCRI) found that the amount of narcotics used by an average injured...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related